IDWeek 2023 Post Show Hero Image

Visit Karius at Booth #402 during the 2024 Critical Care Congress!

January 21-23, 2024
SCCM 2024 Critical Care Congress
Phoenix Convention Center I Phoenix, AZ

Come together with the largest, most diverse global community in critical care to explore the extraordinary advances being made in the treatment of critically ill and injured patients. The Society of Critical Care Medicine’s (SCCM) Critical Care Congress features the achievements and innovation you need to advance your daily practice and ensure the best patient care.

 

The results of the PICKUP Study have been published in Clinical Infectious Diseases.

What is the Karius Test?

The Karius Test is a blood test, based on metagenomic next-generation sequencing (mNGS) of plasma microbial cell-free DNA (mcfDNA). From a single blood sample, the Karius Test can rapidly and non-invasively detect over one thousand pathogens associated with deep-seated and bloodstream infections.

AMR Final Icon NEW ANTIMICROBIAL RESISTANCE DETECTION

In addition to detecting over 1,000 pathogens from blood, the Karius Test now offers a culture-independent method of detection for common AMR markers for 4 classes of antimicrobials across 18 bacterial pathogens:

  • Methicillin-resistant Staphylococci (SCCmec, mecA, mecC)
  • Vancomycin-resistant Enterococci (vanA, vanB)
  • Carbapenem-resistant Gram-negative bacteria (KPC)
  • Extended spectrum beta-lactamase (ESBL)-producing Gram-negative bacteria (CTX-M)

1 blood sample  |  1-day processing*  |  1000+ pathogens

*The Karius Test provides pathogen detection results typically one day after sample receipt, with AMR marker determination available within one day after pathogen results.

The Karius Test® is a laboratory-developed test. The Karius Laboratory is certified under CLIA and accredited by CAP.

Stay up-to-date with Karius

Sign up today to receive notification of future real-world cases of the Karius Test being used by physicians and upcoming events.